To address the relation between APP amyloidogenic processing and Plk2 expression, we used the APP-SwDI mouse model of AD that produces visible amyloid plaques in the hippocampus by 3 months of age in homozygous animals, with further deposition in cortex and thalamus by 6 months [42]. This evidence concerns the gene PLK2 and Alzheimer disease.